Synapse - Michele Ly

Results (17)

Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity

Meeting Abstract

Connell, L. C.; Fiedler, L.; Dickinson, S.; Ly, M.; Harrington, K.; Jarnagin, W. R.; Kingham, T. P.; Drebin, J. A.; Balachandran, V. P.; Wei, A. C.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase II multicenter, open-label study of oral ENMD-2076 for the treatment of patients with advanced fibrolamellar carcinoma

Journal Article

Abou-Alfa, G. K.; Mayer, R.; Venook, A. P.; O'Neill, A. F.; Beg, M. S.; LaQuaglia, M.; Kingham, P. T.; Kobos, R.; Basturk, O.; Brennan, C.; more...
The Oncologist (2020)

Fulltext@MSK | Save

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib

Journal Article

El Dika, I.; Capanu, M.; Chou, J. F.; Harding, J. J.; Ly, M.; Hrabovsky, A. D.; Do, R. K. G.; Shia, J.; Millang, B.; Ma, J.; more...
Cancer Medicine (2020)

Fulltext@MSK | Save

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma

Meeting Abstract

Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings

Journal Article

Maynard, H.; Stadler, Z. K.; Berger, M. F.; Solit, D. B.; Ly, M.; Lowery, M. A.; Mandelker, D.; Zhang, L.; Jordan, E.; El Dika, I.; more...
Cancer (2020)

Fulltext@MSK | Save

Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies

Journal Article

Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Journal Article

Abou-Alfa, G. K.; Qin, S.; Ryoo, B. Y.; Lu, S. N.; Yen, C. J.; Feng, Y. H.; Lim, H. Y.; Izzo, F.; Colombo, M.; Sarker, D.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma

Journal Article

Harding, J. J.; Abu-Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; Capanu, M.; Do, R.; Kemeny, N. E.; O'Reilly, E. M.; more...
Journal of the National Comprehensive Cancer Network (2018)

Fulltext@MSK | Save

Development of an advance care planning paradigm for advanced cancer: Person-centered oncologic care and choices (P-COCC)

Journal Article

Epstein, A. S.; O'Reilly, E. M.; Shuk, E.; Breitbart, W.; Shah, M. A.; Ly, M.; Tayler, R.; Volandes, A. E.
Psycho-Oncology (2017)

Fulltext@MSK | Save

Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention

Meeting Abstract

Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save